Open Access Journal of Neurology & Neurosurgery最新文献

{"title":"The Utility of CEUS as an Intraoperative Tool for Residual Brain Tumors: An Overview","authors":"F. Botero","doi":"10.19080/oajnn.2022.17.555957","DOIUrl":"https://doi.org/10.19080/oajnn.2022.17.555957","url":null,"abstract":"","PeriodicalId":317103,"journal":{"name":"Open Access Journal of Neurology & Neurosurgery","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117058349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long Term Functional Outcome of Patients that Underwent Laminectomy, in Pakistani Population","authors":"Almas Ashraf","doi":"10.19080/oajnn.2022.17.555952","DOIUrl":"https://doi.org/10.19080/oajnn.2022.17.555952","url":null,"abstract":"","PeriodicalId":317103,"journal":{"name":"Open Access Journal of Neurology & Neurosurgery","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134149992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Diagnostic and Treatment Challenges of Adult Rasmussen’s Encephalitis: A Case Report and Literature Review","authors":"Alawi A Al Attas","doi":"10.19080/oajnn.2022.17.555953","DOIUrl":"https://doi.org/10.19080/oajnn.2022.17.555953","url":null,"abstract":"","PeriodicalId":317103,"journal":{"name":"Open Access Journal of Neurology & Neurosurgery","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122283140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of Migraine: An Overview","authors":"G. B. Benitez Lopez","doi":"10.19080/oajnn.2022.17.555951","DOIUrl":"https://doi.org/10.19080/oajnn.2022.17.555951","url":null,"abstract":"Migraine is a disabling type of headache due to a neurovascular disorder characterized by moderate to severe pain and specific associated features. Migraine has a high incidence and prevalence, affecting 20% of people at some point in their lives; women are more affected than men. There have been many pharmacologic options that have been used to treat acute migraine over the last years. Nevertheless, this article aims to point out the new drugs approved by the Food and Drug Administration (FDA), the calcitonin gene-related peptide (CGRP) inhibitor and review the traditional pharmacologic options and their combination available. There are two classes of CGRP inhibitors: small molecule CGRP receptor antagonists and anti-CGRP monoclonal antibodies. Their indications depend on the patient’s comorbidity, preference, and side effects. Due to their non-vasoconstrictive property, CGRP inhibitors can be considered a treatment option for patients with a contraindication of triptans and ergot alkaloids use. Another strategy to treat migraine attacks after they start is triptans. Therefore, this drug is considered an abortive therapy. However, triptans have many contraindications and drug interactions. Additionally, it should not be used for more than ten days per month to avoid the development of medication overuse headaches. Another classic group of drugs proven to be effective and safe for mild to moderate headache therapy is non-steroidal anti-inflammatory drugs (NSAIDs). Their easy access and lower cost are the most attractive advantages of this drug. Migraine treatment is not easy, and it might be necessary to use more than one drug. Combination drugs can be used as a first-line or second-line therapy, and they can also be helpful for refractory migraine treatment. Due to the different mechanisms of action, it can enhance the results of another drug or improve its effects. This treatment regimen can be used as the first or second line, depending on the context of the patient. Since migraine is a prevalent condition, all medical professionals must be up to date on migraine treatment methods because studies in this area are lacking.","PeriodicalId":317103,"journal":{"name":"Open Access Journal of Neurology & Neurosurgery","volume":"58 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128839916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Post COVID-19 Vaccine Encephalitis and Romboencephalitis: Three Cases Report","authors":"Diana Khedr","doi":"10.19080/oajnn.2022.16.555949","DOIUrl":"https://doi.org/10.19080/oajnn.2022.16.555949","url":null,"abstract":"Background: Since introducing the SARS-CoV-2 vaccination, different adverse effects and complications have been linked to the vaccine. Variable neurological complications have been reported after receiving the COVID-19 vaccine, such as acute encephalopathy. Case presentation: In this report, we describe three cases previously healthy men who developed acute cerebellar and brainstem symptoms with temporal relationship to ChAdOx1 nCov-19, CSF investigations showed lymphocytic pleocytosis. They received five days of 1 gm. methylprednisolone with variable response. Discussion: Extensive workup for different causes of acute encephalopathy, including autoimmune encephalitis, was negative. Also, one patient improved dramatically after receiving methylprednisolone, supporting an immune-mediated mechanism behind his acute presentation. Accordingly, we think the COVID-19 vaccine is the only possible cause of our patient’s presentation, giving the temporal relationship and the absence of other risk factors for encephalopathy. Conclusion: of the different COVID-19 vaccines. Further research is needed to clarify the pathophysiology of such complications. Large, pooled data from observational epidemiologic studies are necessary to verify causality.","PeriodicalId":317103,"journal":{"name":"Open Access Journal of Neurology & Neurosurgery","volume":"19 5","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120854971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Acute Management of Crystal-Induced Arthropathies: an Overview","authors":"J. S. Canenguez Benitez","doi":"10.19080/oajnn.2021.16.555931","DOIUrl":"https://doi.org/10.19080/oajnn.2021.16.555931","url":null,"abstract":"Gout and pseudogout are the two major Crystal-induced Arthropathies. Patients with these conditions can experience symptoms such as asymmetric joint pain, swelling, and functional limitation. Acute presentation is due to intra-articular deposition of monosodium urate (Gout) or calcium pyrophosphate (Pseudogout).","PeriodicalId":317103,"journal":{"name":"Open Access Journal of Neurology & Neurosurgery","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125446177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bariatric Surgery as a Complementary Treatment in Patients with Idiopathic Pseudotumor Cerebri: an Overview","authors":"J. S. Canenguez Benitez","doi":"10.19080/oajnn.2021.16.555926","DOIUrl":"https://doi.org/10.19080/oajnn.2021.16.555926","url":null,"abstract":"Idiopathic Intracranial Hypertension (IIH), also known as pseudotumor cerebri, is a syndrome characterized by an increase in intracranial pressure of unknown cause, leading to headaches, frequently in the morning, progressive vision loss, papilledema, pulsatile tinnitus, and in most cases, regular cerebrospinal fluid studies. The most robust and consistent risk factors occur in female patients of reproductive age and those with obesity. This condition in recent years has increased in reported cases due to an escalation in the rate of obesity and unhealthy lifestyles. Currently, there are varying therapeutic options for primary and secondary PTC patients. The first line of therapy includes weight loss and medications such as Acetazolamide, Topiramate. Although corticosteroids have previously been used, they are not recommended due to the risk of weight gain and therefore worsening the symptoms of intracranial hypertension in these patients.","PeriodicalId":317103,"journal":{"name":"Open Access Journal of Neurology & Neurosurgery","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114989054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of Insomnia in Adults: An Overview","authors":"J. S. Canenguez Benitez","doi":"10.19080/oajnn.2021.15.555924","DOIUrl":"https://doi.org/10.19080/oajnn.2021.15.555924","url":null,"abstract":"Insomnia disorder (ID) is a sleep-wake condition characterized by dissatisfaction or complaint with sleep quantity or quality, which can be caused by various causes, such as behavioral and organic comorbidities. ID incurs many problems for patients in their life. This disorder has a real impact on all aspects of the workforce. Healthcare workers can have a decrease in productivity and a decrease in the quality of patient care, which produces a high cost for the health care system in the service provided to patients and the cost that his management incurs.","PeriodicalId":317103,"journal":{"name":"Open Access Journal of Neurology & Neurosurgery","volume":"5 8","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120844270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Combined Pterionally Interhemispheric Approach as a Solution of Double Aneurysms in the Area of Anterior Communicating Artery and Interhemispheric Haematoma and Hemocephalus","authors":"J. Hemza","doi":"10.19080/oajnn.2021.15.555911","DOIUrl":"https://doi.org/10.19080/oajnn.2021.15.555911","url":null,"abstract":"","PeriodicalId":317103,"journal":{"name":"Open Access Journal of Neurology & Neurosurgery","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131518431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Symptomatic Craniovertebral Junction Meningioma","authors":"Jonathan Wong Kee Chi","doi":"10.19080/oajnn.2021.15.555909","DOIUrl":"https://doi.org/10.19080/oajnn.2021.15.555909","url":null,"abstract":"","PeriodicalId":317103,"journal":{"name":"Open Access Journal of Neurology & Neurosurgery","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121011195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}